- Tytuł:
- Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
- Autorzy:
- Źródło:
- In The Lancet 20-26 January 2024 403(10423):271-281
Czasopismo naukowe